N-(3-((2,5-dimethoxybenzyl)oxy)-4-sulfamoylphenyl)-4-methoxybenzamide

ID: ALA4212369

Chembl Id: CHEMBL4212369

PubChem CID: 145965537

Max Phase: Preclinical

Molecular Formula: C23H24N2O7S

Molecular Weight: 472.52

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(C(=O)Nc2ccc(S(N)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)cc1

Standard InChI:  InChI=1S/C23H24N2O7S/c1-29-18-7-4-15(5-8-18)23(26)25-17-6-11-22(33(24,27)28)21(13-17)32-14-16-12-19(30-2)9-10-20(16)31-3/h4-13H,14H2,1-3H3,(H,25,26)(H2,24,27,28)

Standard InChI Key:  HYGSMGQYCBXBSS-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4212369

    ---

Associated Targets(Human)

SK-BR-3 (5175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HSPB1 Tchem Heat shock protein beta-1 (172 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
INS Tbio Insulin (123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 472.52Molecular Weight (Monoisotopic): 472.1304AlogP: 3.19#Rotatable Bonds: 9
Polar Surface Area: 126.18Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 9.72CX Basic pKa: CX LogP: 2.76CX LogD: 2.76
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.49Np Likeness Score: -1.27

References

1. Zhao A, Zheng Q, Orahoske CM, Idippily ND, Ashcraft MM, Quamine A, Su B..  (2018)  Synthesis and biological evaluation of anti-cancer agents that selectively inhibit Her2 over-expressed breast cancer cell growth via down-regulation of Her2 protein.,  28  (4): [PMID:29352646] [10.1016/j.bmcl.2018.01.016]

Source